After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Acadia Pharmaceuticals Inc is $3.99B. A total of 1.62 million shares were traded on the day, compared to an average of 2.20M shares.
In the most recent transaction, Brege Laura sold 14,446 shares of ACAD for 21.78 per share on Jun 04 ’25. After the transaction, the Director now owns 15,095 company shares. In a previous transaction on Jun 04 ’25, LAURA BREGE bought 14,446 shares at 21.78 per share.
Among the insiders who sold shares, Kihara James disposed of 4,000 shares on May 16 ’25 at a per-share price of $22.50. This resulted in the PRINCIPAL ACCOUNTING OFFICER holding 20,395 shares of ACAD after the transaction. In another insider transaction, Schneyer Mark C. sold 2,000 shares at $25.00 per share on May 16 ’25. Company shares held by the EVP, CHIEF FINANCIAL OFFICER now total 62,130.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ACAD has a high of $25.23 and a low of $13.40.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACAD is Buy with a score of 4.10.
